陈关, 潘启超. 3-氨基苯甲酰胺增强平阳霉素的抗瘤作用J. 药学学报, 1985, 20(5): 331-333.
引用本文: 陈关, 潘启超. 3-氨基苯甲酰胺增强平阳霉素的抗瘤作用J. 药学学报, 1985, 20(5): 331-333.
CHEN Guan, PAN Qi-Chao. ENHANCEMENT OF ANTITUMOR ACTIVITY OF BLEOMYCIN A5 BY 3-AMINOBENZAMIDE IN VITRO AND IN VIVOJ. Acta Pharmaceutica Sinica, 1985, 20(5): 331-333.
Citation: CHEN Guan, PAN Qi-Chao. ENHANCEMENT OF ANTITUMOR ACTIVITY OF BLEOMYCIN A5 BY 3-AMINOBENZAMIDE IN VITRO AND IN VIVOJ. Acta Pharmaceutica Sinica, 1985, 20(5): 331-333.

3-氨基苯甲酰胺增强平阳霉素的抗瘤作用

ENHANCEMENT OF ANTITUMOR ACTIVITY OF BLEOMYCIN A5 BY 3-AMINOBENZAMIDE IN VITRO AND IN VIVO

  • 摘要: 3 AB是聚(ADP-R)合成酶抑制剂,能在体外和体内协同地增加平阳霉素对S180的抑制作用,而本身不具有抗瘤与细胞毒作用。这种加强作用与3 AB的剂量有关,剂量加强因子为4。在体内实验中加用3 AB后,平阳霉素对小鼠S180的抑制率由原来的32.3%,41.4%,37.4%和66.0%分别增至60.1%,72.4%,68.3%和77.8%,我们还在体内探讨了量效关系及给药方式的影响。

     

    Abstract: The cytotoxic effects of bleomycin A5 on S180 both in vitro and in rive were synergistically enhanced by 3-aminobenzamide, a potent inhibitor of poly (ADP-ribose) polymerase, at concentrations at which 3-aminobenzamide alone did not show any cytotoxicity. This pontentiation was dependent on the concentration of 3-aminobenzamide with a dose-enhancement factor of about 4 in vitro. The inhibitory rate of bleomycin A5 on S180 in mice was increased from 41.4%, 37.4% and 66.0% to 60.1%, 72.4%, 68.3% and 77.8%, respectively in four separate experimentswhen used in combination with 3-aminobenzamide. The dose-effect relationship in vivo was also investigated.

     

/

返回文章
返回